Method for the treatment of a ubiquitin conjugating disorder

Details Method for the treatment of a ubiquitin conjugating disorder Method for the treatment of a ubiquitin conjugating disorder

2011-08-23

2011-08-23

Bradley, Christina (Department: 1654)

Combinatorial chemistry technology: method, library, apparatus

Method of screening a library

In silico screening

C435S193000

Reexamination Certificate

active

08003572

ABSTRACT:
The present invention provides methods for identifying compounds that selectively bind one or more active sites within an ubiquitin conjugating enzyme. The compounds identified by the methods are useful in the treatment of disorders attributed to dysregulated ubiquitin conjugating enzyme function, specifically in hyperproliferative disorders.

REFERENCES:
patent: 5272157 (1993-12-01), George et al.
patent: 5981699 (1999-11-01), Draetta et al.
patent: 5985857 (1999-11-01), Hudson et al.
patent: 6544997 (2003-04-01), Bosmans et al.
Rolfe et al. (“Reconstitution of p53-ubiquitinylation reactions from purified components: The role of human ubiquitin-conjugating enzyme UBC4 and E6-associated protein (E6AP),” Proc. Acad. Sci. USA, 1995, 92, 3264-8.
Hamilton et al. (“Structure of a Conjugating Enzyme-Ubiquitin Thiolester Intermediate Reveals a Novel Role for the Ubiquitin Tail,” Structure, 2001, 9, 897-904).
Lyne (“Structure-Based Virtual Screening: An Overview,” Drug Discovery Today, 2002, 7, 1047-1055).
Scheffner et al. (“Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53,” Proc. Natl. Acad. Sci., 1994, 91, 8797-8801).
Sadowski (“Tautomer and protonation pre-processor virtual screening,” Abstract of Papers, 224th ACS National Meeting, Boston, MA, Aug. 18-22, 2002).
Pearlman et al. (“ProtoPlex: user-control over tautomeric and protonation state,” Abstract of Papers, 224th ACS National Meeting, Boston, MA, Aug. 18-22, 2002).
Hershko, A., and Ciechanover, A.(1992) Ann Rev Biochem 61: 761-807. The ubiquitin System for protein degradation.
Goettsch, S. and Bayer, P.(2002) Frontiers in Bioscience, 7, a148-162. Structural attributes in the conjunction of Ubiquitin, RUB and SUMO to protein substrates. Hershko, et al. J. Biol. Chem., 269:4940-46.
“Overexpression of E2F-1 in Lung and Liver Metastases of Human Colon Cancer is Associated with Gene Amplification”, Iwamoto, et al. Cancer Biol Ther. Apr. 2004; 3(4):395-399.
“UbcH10 is the Cancer-related E2 Ubiquitin-conjugating Enzyme” Okamoto, et al. Cancer Res. 2003 63(14): 4167-73.
Shirahata A. et al, Enzymatic aminopropylation of certain secondary amines. Biol.Pharm.Bull. Feb. 1995; 18(2):355-9.
International Search Report for PCT/US05/28358 dated Sep. 21, 2006.

Affiliated with

Also associated with

Rating

Method for the treatment of a ubiquitin conjugating disorder does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for the treatment of a ubiquitin conjugating disorder, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the treatment of a ubiquitin conjugating disorder will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2737695